Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
462
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Celltrion Inc
•
23 Aug 2017 04:03
More Discussions on Impacts of Celltrion's KOSPI200 Inclusion
Celltrion Inc (068270 KS) said in a regulatory filing that it will have EGM at 10 AM on Aug 29 to decide whether it will move to KOSPI. Below is...
Sanghyun Park
Follow
493 Views
Share
bearish
•
Celltrion Inc
•
10 Aug 2017 19:54
NPS' Passive Investing May Come to an End - Impact on Celltrion's KOSPI Move
Interesting news came out for Celltrion Inc (068270 KS). Celltrion's retail investors are now demanding a KOSPI move from KOSDAQ. Nearly 10,000...
Sanghyun Park
Follow
1.4k Views
Share
bearish
•
Celltrion Healthcare
•
31 Jul 2017 01:45
Recap on Celltrion Healthcare IPO Day - Retail Investors Turned Positive, Why?
Celltrion Healthcare (091990 KS)'s performance on its market debut day was a bit of a surprise. Of course, given that the IPO price was set at the...
Sanghyun Park
Follow
163 Views
Share
bearish
•
Celltrion Inc
•
19 Jul 2017 06:14
JNJ's REMICADE Holds: PFE's Results To Confirm
Johnson & Johnson (JNJ US) reported Q2 2017 results today (quotes from earnings call are below). US revenue for REMICADE (reference product for...
Kemp Dolliver, CFA
508 Views
Share
bearish
•
Celltrion Healthcare
•
17 Jul 2017 13:39
Celltrion Healthcare IPO Part 5 - Regulatory Concerns & Possible M&A Options
Korea's Anti-Trust Law now says that any business group (those so-called chaebols or large conglomerates) with combined assets of ₩10tril are...
Sanghyun Park
Follow
179 Views
Share
First
Previous
74
75
76
77
78
79
80
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x